mail
versión imprimible
 
 

4th Treg Directed Therapies Summit

Evvnt Promotion / evvnt
-
17.05.2022 - 19.05.2022  Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, USA
Time: 09:00 - 17:30
 
Temas de la conferencia
As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy.

The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Richard Ransohof, Co-Founder and CMO Abata and Venture Partner, Third Rock Ventures, Thomas Wickham, CSO, GentiBio, Jonathan Zalevsky, Chief Research and Development Officer, Nektar Therapeutics and more.
 

Información e inscripción:

https://go.evvnt.com/991160-2?pid=4832
Mr. Treg Directed Therapies Summit Team
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.0 - USD 5846.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AMREF - African Medical and Research FoundationEuropean Health Forum GasteinÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität WienÄrztekammer für WienÖsterreichische Gesellschaft für Public HealthnewTreeOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation